Lancet. 1955 Feb 26;268(6861):434-5. doi: 10.1016/s0140-6736(55)90215-4.
PMID:13234410
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators.
Cardiovascular safety of prokinetic agents: A focus on drug-induced arrhythmias.
Giudicessi JR, Ackerman MJ, Camilleri M.
Neurogastroenterol Motil. 2018 Jun;30(6):e13302. doi: 10.1111/nmo.13302. Epub 2018 Feb 14.
PMID:29441683
Proton Pump Inhibitors.
[No authors listed]
2019 Apr 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
PMID:31643228
CT imaging findings of lenvatinib-induced enteritis.
Kurokawa R, Hagiwara A, Tanishima T, Inui S, Kurokawa M, Nakaya M, Gonoi W, Amemiya S, Nakai Y, Fujita N, Ota Y, Baba A, Abe O.